$BCTX BriaCell announces GMP manufacturing of Bria-Pros+, a personalized cellular cancer vaccine for prostate cancer. Bria-Pros+ activates multiple immune cells to fight tumors. Pre-clinical data shows promising results. https://www.globenewswire.com/news-release/2024/2/6/2824344/0/en/Breaking-Ground-in-Prostate-Cancer-BriaCell-Announces-Lead-Prostate-Cancer-Candidate-Bria-Pros-Initiates-GMP-Manufacturing.html Major News Alert: BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) Breaking Ground in Prostate Cancer: Major Milestone with BriaCell’s Off-The-Shelf Personalized Cellular Cancer Vaccines #cancer #immunotherapy $BCTX